Anti-Rheumatics Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2022-27 - PowerPoint PPT Presentation

About This Presentation
Title:

Anti-Rheumatics Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2022-27

Description:

Looking forward, the anti-rheumatics market value is projected to reach a strong growth during the forecast period (2022-2027). More info:- – PowerPoint PPT presentation

Number of Views:7
Date added: 21 June 2022
Slides: 15
Provided by: IMARC
Category: Other

less

Transcript and Presenter's Notes

Title: Anti-Rheumatics Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2022-27


1
Global Anti-Rheumatics Market Research and
Forecast Report 2022-2027




Author Elena Anderson Marketing Manager IMARC
Group
2022 IMARC All Rights Reserved
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2
About IMARC Group
Report Description
International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all regions
and industry verticals to identify their
highest-value opportunities, address their most
critical challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Anti-Rheumatics Market Research Report
2022-2027 According to the latest report by
IMARC Group, titled Anti-Rheumatics Market
Global Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2022-2027," the global
anti-rheumatics market reached a value of US
61.1 Billion in 2021. Rheumatoid arthritis is a
chronic, autoimmune disease that affects the
joints, articular tissues, and extra-articular
organs. It is a progressive disorder that results
in pain, inflammation, stiffness, and swelling of
joints. Anti-rheumatics refer to drugs used to
manage different symptoms of rheumatoid arthritis
and modify the course of the disease. They can be
administered subcutaneously (SC), orally, or
intravenously (IV) into the body of the patient.
Anti-rheumatics are also used to treat various
types of cancer, and bowel, connective tissue,
and autoimmune conditions, such as psoriatic
arthritis, lupus, Sjogren syndrome (SS), systemic
sclerosis (SSc), and systematic lupus
erythematosus. Medical practitioners usually
prescribe the drug to reduce pain, prevent bone
deformity,  reduce joint damage, preserve the
structure and function of the joints, slow the
progression of arthritis, and improve the
persons overall function. Request for a PDF
sample of this report https//www.imarcgroup.com/
anti-rheumatics-market/requestsample

4
Report Description and Highlights
Report Description
Global Anti-Rheumatics Market Trends The
rising incidences of rheumatoid arthritis,
especially among the steadily growing geriatric
population, are creating a positive outlook for
the market. Anti-rheumatic drugs are widely used
to treat rheumatoid arthritis and inflammatory
diseases that cause swelling in joints and damage
the eyes, lungs and skin. In line with this, the
increasing incidences of obesity due to unhealthy
eating habits and changing lifestyles of the
masses are further favoring the market growth.
Apart from this, rapid technological advancements
in the field of biosimilars and novel biologic
therapies that act faster than conventional drugs
and are provided in combination with the
disease-modifying anti-rheumatic drug (DMARD) to
patients are providing an impetus to the market
growth. Moreover, the widespread adoption of
prescription-based medications due to the
increasing number of specialized hospitals
worldwide is augmenting the market growth. Other
factors, including the rising expenditure
capacities of consumers, availability of early
diagnosis and treatment options, and continuous
research and development (RD) activities to
lower the side effects of the drug, are
anticipated to drive the market toward growth. On
account of the aforementioned factors, the market
is anticipated to reach a value of US 72.1
Billion by 2027, growing at a CAGR of 2.74
during 2022-2027. View Report TOC, Figures and
Tables https//www.imarcgroup.com/anti-rheumatics
-market

5
Report Description and Highlights
Report Description
  • Key Market Segmentation
  • The research report includes the following
    segments
  • Breakup by Type
  • Prescription-based Drugs
  • Over-the-Counter Drugs
  •  
  • Breakup by Route of Drug Administration
  • Oral
  • Parenteral
  • Others
  • Breakup by Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce


6
Report Description and Highlights
Report Description
  •  
  • Breakup by Drug Class
  • Disease Modifying Anti-Rheumatics Drugs (DMARD's)
  • Nonsteroidal Anti-Inflammatory Drugs (NSAID's)
  • Corticosteroids
  • Uric Acid Drugs
  • Others
  • Breakup by Region
  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • Middle East and Africa
  •  


7
Report Description and Highlights
Report Description
  •  
  • Competitive Landscape with Key Players
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca plc
  • Biogen Inc.
  • Bristol-Myers Squibb Company
  • Celltrion Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Johnson Johnsons
  • Pfizer Inc.
  • Sanofi SA.
  •  


8
Key Questions Answered in the Report
Report Description
  • How has the global anti-rheumatics market
    performed so far and how will it perform in the
    coming years?
  • What has been the impact of COVID-19 on the
    global anti-rheumatics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the
    type?
  • What is the breakup of the market based on the
    drug class?
  • What is the breakup of the market based on the
    route of drug administration?
  • What is the breakup of the market based on the
    distribution channel?
  • What are the various stages in the value chain of
    the industry?
  • What are the key driving factors and challenges
    in the industry?
  • What is the structure of the global
    anti-rheumatics market and who are the key
    players?
  • What is the degree of competition in the
    industry?
  •  

9
Table of Contents
Report Description
1   Preface2   Scope and Methodology    2.1  
 Objectives of the Study    2.2  
 Stakeholders    2.3    Data Sources       
2.3.1    Primary Sources        2.3.2  
 Secondary Sources    2.4    Market Estimation 
      2.4.1    Bottom-Up Approach        2.4.2  
 Top-Down Approach    2.5    Forecasting
Methodology3   Executive Summary4  
Introduction    4.1    Overview    4.2    Key
Industry Trends5   Global Anti-Rheumatics
Market    5.1    Market Overview    5.2  
 Market Performance    5.3    Impact of
COVID-19    5.4    Market Forecast

10
Table of Contents
Report Description
6   Market Breakup by Type    6.1  
 Prescription-based Drugs        6.1.1 Market
Trends        6.1.2 Market Forecast    6.2  
 Over-the-Counter Drugs        6.2.1 Market
Trends        6.2.2 Market Forecast7   Market
Breakup by Drug Class    7.1    Disease
Modifying Anti-Rheumatics Drugs (DMARD's)       
7.1.1 Market Trends        7.1.2 Market
Forecast    7.2    Nonsteroidal
Anti-Inflammatory Drugs (NSAID's)        7.2.1
Market Trends        7.2.2 Market Forecast   
7.3    Corticosteroids        7.3.1 Market
Trends        7.3.2 Market Forecast         
Click here to visit the complete table of
content with list of figures and tables
https//www.imarcgroup.com/anti-rheumatics-market/
toc

11
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
12
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
13
Report Description and Highlights
Report Description

2022 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
14

Contact Us
Write a Comment
User Comments (0)
About PowerShow.com